Published in Sex Transm Dis on February 01, 2009
Condom effectiveness for reducing transmission of gonorrhea and chlamydia: the importance of assessing partner infection status. Am J Epidemiol (2004) 2.49
Detection of Chlamydia trachomatis by nucleic acid amplification testing: our evaluation suggests that CDC-recommended approaches for confirmatory testing are ill-advised. J Clin Microbiol (2006) 2.14
Seroprevalence and correlates of herpes simplex virus type 2 infection in five sexually transmitted-disease clinics. J Infect Dis (2002) 2.08
California guidelines for expedited partner therapy for Chlamydia trachomatis and Neisseria gonorrhoeae. Sex Transm Dis (2008) 2.03
Prevalence of and associated risk factors for fluoroquinolone-resistant Neisseria gonorrhoeae in California, 2000-2003. Clin Infect Dis (2005) 2.01
Population-based genetic and evolutionary analysis of Chlamydia trachomatis urogenital strain variation in the United States. J Bacteriol (2004) 1.94
Chlamydia trachomatis among patients infected with and treated for Neisseria gonorrhoeae in sexually transmitted disease clinics in the United States. Ann Intern Med (2003) 1.86
Head-to-head multicenter comparison of DNA probe and nucleic acid amplification tests for Chlamydia trachomatis infection in women performed with an improved reference standard. J Clin Microbiol (2002) 1.85
Incidence of herpes simplex virus type 2 infection in 5 sexually transmitted disease (STD) clinics and the effect of HIV/STD risk-reduction counseling. J Infect Dis (2004) 1.79
Repeat infection with Chlamydia and gonorrhea among females: a systematic review of the literature. Sex Transm Dis (2009) 1.69
HIV incidence among men diagnosed with early syphilis in Atlanta, San Francisco, and Los Angeles, 2004 to 2005. J Acquir Immune Defic Syndr (2008) 1.68
Patient-delivered partner treatment with azithromycin to prevent repeated Chlamydia trachomatis infection among women: a randomized, controlled trial. Sex Transm Dis (2003) 1.56
Intimate partner violence and high-risk sexual behaviors among female patients with sexually transmitted diseases. Sex Transm Dis (2002) 1.45
Neonatal herpes morbidity and mortality in California, 1995-2003. Sex Transm Dis (2008) 1.43
Screening for syphilis with the treponemal immunoassay: analysis of discordant serology results and implications for clinical management. J Infect Dis (2011) 1.28
Neisseria gonorrhoeae antimicrobial resistance among men who have sex with men and men who have sex exclusively with women: the Gonococcal Isolate Surveillance Project, 2005-2010. Ann Intern Med (2013) 1.27
Problems with condom use among patients attending sexually transmitted disease clinics: prevalence, predictors, and relation to incident gonorrhea and chlamydia. Am J Epidemiol (2007) 1.19
A response to "developing standards in behavioral surveillance for HIV/STD prevention". AIDS Educ Prev (2002) 1.18
Impact of patient characteristics on performance of nucleic acid amplification tests and DNA probe for detection of Chlamydia trachomatis in women with genital infections. J Clin Microbiol (2005) 1.17
Seroepidemiology of infection with human papillomavirus 16, in men and women attending sexually transmitted disease clinics in the United States. J Infect Dis (2004) 1.17
Perforin and gamma interferon are critical CD8+ T-cell-mediated responses in vaccine-induced immunity against Leishmania amazonensis infection. Infect Immun (2003) 1.16
Population-based genetic epidemiologic analysis of Chlamydia trachomatis serotypes and lack of association between ompA polymorphisms and clinical phenotypes. Microbes Infect (2006) 1.15
Chlamydia screening of youth and young adults in non-clinical settings throughout California. Sex Transm Dis (2004) 1.08
Steps to a sustainable public health surveillance enterprise a commentary from the international society for disease surveillance. Online J Public Health Inform (2013) 1.02
An observational cohort study of Chlamydia trachomatis treatment in pregnancy. Sex Transm Dis (2006) 1.01
Recommendations for the selective use of herpes simplex virus type 2 serological tests. Clin Infect Dis (2004) 1.01
Socioeconomic gradients in sexually transmitted diseases: a geographic information system-based analysis of poverty, race/ethnicity, and gonorrhea rates in California, 2004-2006. Am J Public Health (2010) 1.00
Sex, drugs (methamphetamines), and the Internet: increasing syphilis among men who have sex with men in California, 2004-2008. Am J Public Health (2012) 0.93
Sexually transmitted diseases and risk behaviors among California farmworkers: results from a population-based survey. J Rural Health (2008) 0.93
An evaluation of the relative sensitivities of the venereal disease research laboratory test and the Treponema pallidum particle agglutination test among patients diagnosed with primary syphilis. Sex Transm Dis (2007) 0.92
Chlamydia trachomatis and Neisseria gonorrhoeae infections among men and women entering California prisons. Am J Public Health (2006) 0.92
Chlamydia partner services for females in California family planning clinics. Sex Transm Dis (2011) 0.91
Association between physician compensation methods and delivery of guideline-concordant STD care: is there a link? Am J Manag Care (2005) 0.89
Chlamydia screening and management practices of primary care physicians and nurse practitioners in California. J Gen Intern Med (2005) 0.86
Are counselor demographics associated with successful human immunodeficiency virus/sexually transmitted disease prevention counseling? Sex Transm Dis (2004) 0.84
Repeat syphilis among men who have sex with men in California, 2002-2006: implications for syphilis elimination efforts. Am J Public Health (2011) 0.81
Strain typing and antimicrobial resistance of fluoroquinolone-resistant Neisseria gonorrhoeae causing a California infection outbreak. J Clin Microbiol (2009) 0.79
Patient-delivered partner therapy for chlamydial infections: attitudes and practices of California physicians and nurse practitioners. Sex Transm Dis (2006) 0.77
A closer look at age: deconstructing aggregate gonorrhea and chlamydia rates, California, 1998-2007. Sex Transm Dis (2010) 0.77
Repeating low-positive nucleic acid amplification test results for Chlamydia trachomatis and Neisseria gonorrhoeae: assessment of current practice in selected california public- and private-sector laboratories. J Clin Microbiol (2011) 0.77
Cost-effectiveness of Chlamydia vaccination programs for young women. Emerg Infect Dis (2015) 0.77
Trends in the use of sexually transmitted disease diagnostic technologies in California, 1996-2003. Sex Transm Dis (2007) 0.77
Longitudinal HIV Care Trajectories in North Carolina. J Acquir Immune Defic Syndr (2017) 0.75
Neisseria gonorrhoeae outbreak: unintended consequences of electronic medical records and using an out-of-state laboratory-California, July 2009-February 2010. Sex Transm Dis (2013) 0.75
Influence of Detection Method and Study Area Scale on Syphilis Cluster Identification in North Carolina. Sex Transm Dis (2016) 0.75
Pre-treatment integrase strand transfer inhibitor resistance in north carolina from 2010-2016. AIDS (2017) 0.75
Screening for Syphilis and Other Sexually Transmitted Infections in Pregnant Women - Guam, 2014. MMWR Morb Mortal Wkly Rep (2017) 0.75
The role of Medicaid managed care interventions in Chlamydia screening by physicians. Sex Transm Dis (2011) 0.75
Syphilis outbreak at a California men's prison, 2007-2008: propagation by lapses in clinical management, case management, and public health surveillance. J Correct Health Care (2012) 0.75
Pretreatment integrase strand transfer inhibitor resistance in North Carolina from 2010-2016. AIDS (2017) 0.75
Tackling multidrug-resistant gonorrhea: how should we prepare for the untreatable? Expert Rev Anti Infect Ther (2012) 0.75